登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>Spike RBD >RAS-T026

Anti-SARS-CoV-2 (B.1.1.7) Antibody IgG Titer Serologic Assay Kit (Spike RBD)

For research use only.

IDComponentsSize
RAS026-C01Pre-coated SARS-CoV-2 Spike RBD (B.1.1.7) Microplate1 plate
RAS026-C02Positive Control100 μL
RAS026-C03Negative Control100 μL
RAS026-C04HRP-Anti-Human IgG200 μL
RAS026-C0510xWashing Buffer50 mL
RAS026-C06Dilution Buffer50 mL
RAS026-C07Substrate Solution12 mL
RAS026-C08Stop Solution7 mL

背景(Background)

Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. The variant B.1.1.7 identified in the United Kingdom (UK) carries a large number of mutations and is reported to spread more easily and quickly than other variants. The variant B.1.351 identified in South Africa and P.1 identified in Brazil show evidence of increased transmissibility and resistance to established immunity. A common mutation identified in the U.K., South African and Brazilian variants is N501Y, which resides on the receptor-binding domain (RBD) of SARS-CoV-2 spike protein. To evaluate the impacts of the new variants, a rapid and effective assay kit detecting the levels of antibody against the mutant is in urgent need.

应用说明(Application)

This kit is developed for serologic test for IgG titer of Anti-SARS-CoV-2 Spike RBD antibody in serum/plasma in vitro. The Spike RBD antigen used in this kit contains the N501Y mutation found in the U.K. variant (known as B.1.1.7, 20B/501Y.V1 or VOC 202012/01), the South African variant (known as B.1.351 or 20C/501Y.V2) and the Brazilian variant (known as P.1).

It is for research use only.

重构方法(Reconstitution)

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储 & 运输(Storage & Shipping)

1. Unopened kit should be stored at 2℃-8℃ upon receiving.

2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

Shipping Statement

原理(Assay Principles)

This assay kit employs a standard indirect-ELISA format, providing a rapid detection of Anti-SARS-CoV-2 antibodies in serum by SARS-CoV-2 Spike RBD. The kit consists of Pre-coated SARS-CoV-2 Spike RBD Microplate, an Positive Control, an Negative Control, an HRP-Anti-Human IgG secondary antibody and related buffer.

Your experiment will include 4 simple steps:

a) Add your sample to the plate. The samples and Control sample are diluted by Dilution Buffer.

b) Add diluted Secondary antibody HRP-Anti-Human IgG to the plate. The Secondary antibody is diluted by Dilution Buffer.

c) Wash the plate and add TMB or other colorimetric HRP substrate.

d) Stop the substrate reaction by add diluted acid. Absorbance (OD) is calculated as the absorbance at 450 nm minus the absorbance at 630 nm to remove background prior to statistical analysis. The OD Value reflects the amount of antibody bound.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

Spike RBD TYPICAL DATA

Detection of Monoclonal Anti-SARS-CoV-2 Antibody IgG titer by Indirect-ELISA Assay.
Immobilized SARS-CoV-2 Spike RBD at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-SARS-CoV-2 Antibody, Human IgG in 1:400 human serum. Detection was performed using HRP-Anti-human IgG antibody with sensitivity of 39 ng/mL (QC tested).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定